A Concise Overview of Biosensing Technologies for the Detection ofAlzheimer's Disease Biomarkers / Marjan Talebi, Hadi Esmaeeli, Mohsen Talebi, Tahereh Farkhondeh, Saeed Samarghandian
Abstract: Alzheimer's disease (AD) is a brain-linked pathophysiological condition with neuronal degenerationand cognition dysfunctions and other debilitations. Due to the growing prevalence of AD,there is a highly commended trend to accelerate and develop analytical technologies for easy, costeffective,and sensitive detection of AD biomarkers. Biosensors are commanding analytical devices thatcan conduct biological responses on transducers into measurable signals. This review focuses on up-todatedevelopmets, contests, and tendencies regarding AD biosensing principally, with the emphasis onthe exclusive possessions of nanomaterials. In the last decade, remarkable advancements have beenachieved to the progression of biosensors, predominantly optical and electrochemical, for the detectionof AD biomarkers. These analytical devices can assist the case finding and management of AD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Current pharmaceutical biotechnology - 23(2022), 5, Seite 11 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Talebi, Marjan [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (11 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL011171898 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011171898 | ||
| 003 | DE-627 | ||
| 005 | 20231128145604.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230613s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL011171898 | ||
| 035 | |a (KFL)prod_DARH_.D9B2450313960D244FC24D28A36C8E29C1A383AC | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Talebi, Marjan |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Concise Overview of Biosensing Technologies for the Detection ofAlzheimer's Disease Biomarkers |c Marjan Talebi, Hadi Esmaeeli, Mohsen Talebi, Tahereh Farkhondeh, Saeed Samarghandian |
| 264 | 1 | |c 2022 | |
| 300 | |a 1 Online-Ressource (11 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract: Alzheimer's disease (AD) is a brain-linked pathophysiological condition with neuronal degenerationand cognition dysfunctions and other debilitations. Due to the growing prevalence of AD,there is a highly commended trend to accelerate and develop analytical technologies for easy, costeffective,and sensitive detection of AD biomarkers. Biosensors are commanding analytical devices thatcan conduct biological responses on transducers into measurable signals. This review focuses on up-todatedevelopmets, contests, and tendencies regarding AD biosensing principally, with the emphasis onthe exclusive possessions of nanomaterials. In the last decade, remarkable advancements have beenachieved to the progression of biosensors, predominantly optical and electrochemical, for the detectionof AD biomarkers. These analytical devices can assist the case finding and management of AD | ||
| 700 | 1 | |a Esmaeeli, Hadi |e verfasserin |4 aut | |
| 700 | 1 | |a Talebi, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Farkhondeh, Tahereh |e verfasserin |4 aut | |
| 700 | 1 | |a Samarghandian, Saeed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d Hilversum : Bentham Science Publ., 2000 |g 23(2022), 5, Seite 11 |h Online-Ressource |w (DE-627)KFL00000636X |w (DE-600)2044611-1 |w (DE-576)273880926 |x 1873-4316 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:5 |g pages:11 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1389-2010&volume=23&issue=5&spage=634 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_DARH_03 | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |e 5 |h 11 | ||